Effects of SVAK-12 injection on the relative torsional strength (a) and stiffness (b) five weeks after fracture. The value for the treated fracture was calculated as a percentage of the value for the unfractured femur. There was a significant difference in the relative torsional strength (p = 0.004) between the vehicle-treated group and the SVAK-12-treated group. The relative torsional stiffness in the SVAK-12-treated group was more than twice that in the untreated fracture group (*p = 0.002) and the vehicle-treated group (**p = 0.04).

Fig. 6-A.

Fig. 6-B.